NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO
Delisted
NWBO was delisted on the 16th of December, 2016.
80 hedge funds and large institutions have $124M invested in Northwest Biotherapeutics, Inc. Common stock in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
41% less capital invested
Capital invested by funds: $211M → $124M (-$86.5M)
Holders
80
Holding in Top 10
1
Calls
$2.74M
Puts
$2.65M
Top Buyers
| 1 | +$17.5M | |
| 2 | +$1.11M | |
| 3 | +$653K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$484K |
| 5 |
Morgan Stanley
New York
|
+$402K |
Top Sellers
| 1 | -$2.53M | |
| 2 | -$1.71M | |
| 3 | -$320K | |
| 4 |
PG
PEAK6 Group
Chicago,
Illinois
|
-$315K |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
-$201K |